How the Medical Establishment Normalized a Pathway to Abilify and Antipsychotics

Executive Summary

• Antidepressants like SSRIs are ineffective.
• This ineffectiveness can lead to a person being prescribed antipsychotics like Abilify.

Introduction

The medical establishment has made enormous sums of money from SSRIs, the dominant category of antidepressants. Research published in the journal Nature now shows that the hypothesis of how SSRIs work cannot reduce depression.

This article covers how pharmaceutical companies and medical authorities gaslight patients who see no benefit from SSRIs to move to full antipsychotics — without even informing these patients that SSRIs do not work to reduce depression or anxiety beyond the placebo effect.

This video makes a number of false claims, in particular, that SSRIs are effective against depression. One true statement is that a rise in serotonin caused by SSRIs does not correspond with an elevation in the mood of the test subject — however, further research has shown that there is no relationship between serotonin level and depression — which is the foundational hypothesis of SSRIs. This video brings up a bunch of explanations that are really only hypotheses and are a type of cover story for why SSRIs don’t work at all. 

Any person watching this video can learn close to nothing from it. The viewer is not told that Ability is an antipsychotic. They are not told it was originally designed for those with schizophrenia. 

The Illogic of Moving to Antipsychotics After SSRIs, That Don’t Work, End Up Not Working

The fact that patients are tricked into thinking that if SSRIs don’t work for them, which they won’t, they should move to a drug like Abilify, which is for institutionalized patients, is dishonest and irresponsible to the nth degree.

Schizophrenia is a rare disorder, yet, the FDA gave pharmaceutical companies the right to prescribe it to people who found antidepressants did not work. This is explained in the following quotation.

Although schizophrenia affects more than 3 million individuals in the United States and is associated with substantial psychiatric, substance-related, and medical comorbidity, patterns of comorbidity in schizophrenia have not been systematically described using real-word data. – Psychiatric Times

This means people are being put on Abilify, or an antipsychotic, without being diagnosed with schizophrenia — but instead, because their SSRIs don’t work.

This video explains that antipsychotics are for patients who cannot determine what is real. This is textbook schizophrenia. I have an uncle with schizophrenia who has major impulse control issues and cannot focus on things that make sense. So he has an obsession with finding gold and with collecting plants.

The question arises if antipsychotics are being prescribed to people who are coming into a medical office — how are they able to find their way to the doctor’s office and take the drugs effectively? This classification of drugs has enormous side effects and only can be justified for people who cannot function outside of an institutionalized environment or some highly controlled environment.